See every side of every news story
Published Updated

Illinois patients, pharmacies struggle as PBMs drive up costs, limit access (copy)

  • In Illinois, lawmakers and Governor Pritzker are addressing concerns about pharmacy benefit managers and their impact on drug costs and access for patients, particularly those economically vulnerable, as well as the viability of independent pharmacies.
  • Independent pharmacies contend that an increasingly complicated reimbursement system, influenced by PBMs, makes it difficult for them to compete, sometimes leading to closure and leaving communities without a local pharmacy.
  • Heather Anderson, a 47-year-old Springfield resident, received a package containing her prescribed medication Stelara that was not properly chilled, and an Accredo representative, a subsidiary of the PBM Express Scripts, initially advised her to use it anyway, causing her distress.
  • Governor Pritzker stated during his State of the State address in February that high drug costs are making medications unaffordable, and Dave Falk, who owns 10 independent pharmacies, noted that PBMs' payment methods have caused a loss of business.
  • Proposed legislation, such as SB 2385 in Illinois and SB 252 in Alabama, aims to curb PBM abuses by stopping steering, mandating fair reimbursement, requiring annual pricing reports, and prohibiting certain fees, with the goal of helping both pharmacies and patients.
Insights by Ground AI
Does this summary seem wrong?

13 Articles

All
Left
4
Center
3
Right
1
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Indiana Capital Chronicle broke the news in on Wednesday, March 26, 2025.
Sources are mostly out of United States (3)

Similar News Topics

You have read 5 out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.